The medical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a exciting development. Unlike shots, this technique offers a more convenient way to administer GLP-1 therapies. These devices gradually release the treatment through the skin offering a stable level of the beneficial agent, which can enhance glucose